Prospective Study of Pravastatin in the Elderly at Risk
Initiatives
-
The aim was to test the benefits of pravastatin treatment in an elderly cohort of men and women with, or at high risk of developing, cardiovascular disease and stroke.
*Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
- Start Year
- 1997
- End Year
- 2001
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Patients' cohort
- Follow Up
- Follow-up was 3.2 years on average
Marker Paper
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x.
PUBMED 12457784
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 649
- Number of participants with biosamples
- Supplementary Information
- Aged 70-82 years
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |